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Hypo-osmolar aerosol induces hyperventilation in 
chronic non-asthmatic rhinitics 
A. L. COGO+, M. FERRARI”, A. FUGAGNOLI*, C. MICHELETTO~ AND A. CIACCIA* 
“Institute of Infectious and Respivatovy Diseases, University of Fevrava, Italy 
‘Depavtwlent of Clinical Respiratory Physiology, Bussolengo Hospital, Verona, Italy 
The effect of a hypo-osmolar aerosol on transcutaneous 0, and CO, time course (PtcO,, PtcCO,) was investigated 
in subjects affected by chronic non-atopic rhinitis, without any history of asthmatic symptoms and no airways 
hyper-responsiveness. 
Twelve normal subjects and 12 subjects affected by chronic idiopathic rhinitis, who had normal responsiveness to 
both hypo-osmolar aerosol and methacholine challenge as measured by the decrease in FEV, (mean FEV, 
decrease=5% and PC,, > 16 mg, respectively) were studied. By means of a transcutaneous mono-electrode, it was 
possible to study the time course of PtcO, and PtcCO, during and after a 5-min inhalation of ultrasonically 
nebulized distilled water (output 2 mllmin ~ ‘). A significant decrease in PtcCO, and increase in PtcO, were observed 
during the challenge in rhinitics as compared with normal subjects [maximum decrease and maximum increase 
expressed as mean value ( f SD) were - 22% ( i 6.9) and + 12.6% ( f 7.2), respectively]. No significant changes in 
either PtcCO, and PtcO, were observed after the test. 
The results of this study suggest that patients affected by idiopathic chronic rhinitis with absence of bronchial 
hyper-responsiveness may present a hyperventilatory response to the inhalation of hypo-osmolar aerosol; the 
mechanism of such a response might be due to an upregulation of the irritant receptors of the upper airways. 
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Introduction 
Rhinitis is often associated with airway hyper- 
responsiveness in both asthmatic and non-asthmatic sub- 
jects. Bronchial responsiveness is enhanced in asthmatics 
during and after an upper respiratory tract infection (1,2) 
and a transient increase in bronchial responsiveness has 
been demonstrated in otherwise normal subjects after a 
viral upper respiratory tract infection (3,4). Bronchial 
hyper-responsiveness is also known to affect a variable 
percentage of atopic, non-asthmatic rhinitics (5-7): rhinitis 
and atopy are therefore risk factors for bronchial hyper- 
responsiveness, particularly when considering the common 
structural involvement along airways. A variable percent- 
age of rhinitic subjects is, however, found not to be 
responsive to bronchial challenges. 
In non-asthmatic, never-wheezing atopic rhinitics, trans- 
cutaneous monitoring of blood gas has recently been 
proved to allow the identification of an airways response to 
hypo-osmolar challenge, even at levels of stimulus which 
do not cause any significant decrease in FEV, (8,9). 
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These subjects have not been submitted to methacholine 
challenge. 
The aim of the present study was to investigate the 
pattern of transcutaneous blood gas changes induced by the 
inhalation of hypo-osmolar aerosol in subjects affected by 
chronic non-atopic rhinitis, with no history of asthma 
or wheezing and no spirometric response to either 
methacholine or distilled water. 
Methods 
SUBJECT SELECTION 
Twelve non-smoking subjects [seven females, five males, 
mean age 24.3 (& 7.3) years] with a history of usual or 
chronic non-atopic rhinitis, without any history of 
asthmatic symptoms and no airways hyper-responsiveness 
were enrolled in this study. Chronic rhinitics are usually 
referred to the authors’ pulmonary outpatients clinic by 
the ear-nose-throat specialist in order to investigate the 
presence of bronchial hyper-responsiveness. 
Subjects were therefore selected from outpatients attend- 
ing the authors’ clinic suffering from chronic rhinitis and 
with no evidence of bronchial responsiveness. 
For all subjects, a case history was taken and a physical 
examination was performed. All were requested to fill in a 
questionnaire to determine the presence and the intensity of 
0 1998 W. B. SAUNDERS COMPANY LTD 
10 A. L. COG0 ETAL. 
nasal symptoms. According to Annesi (10) symptoms of 
‘usual’ and ‘chronic’ rhinitis were respectively defined as 
stuffy or runny nose for most of the year, and stuffy and 
runny nose for most days for as much as 3 months of the 
year; anamnestic reports of frequent watery secretion and 
sneezing induced by various stimuli such as cold air or 
tobacco smoke were also investigated. 
The ENT specialist made the diagnosis both on the basis 
of anamnestic reports and nasal endoscopy: nasal dis- 
charge, mucoid secretions, pale mucosa in nasopharynge 
and oropharynge and/or a cobblestone appearance of 
turbinate. The presence of postnasal drip was also 
investigated. 
Subjects aff‘ected by acute, infective rhinitis or rhino- 
sinusitis or other conditions which might simulate rhinitis 
(i.e. mechanical factors, granulomatous conditions) (11) 
were excluded from the study as were subjects affected by 
nasal polyposis, which is known to often be associated with 
increased airway responsiveness (12). 
All subjects were submitted to allergen skin testing by 
prick method in response to common allergens (pollen mix, 
house dust, Dermatophagoides farinae and pteronyssinus). 
Atopic patients were excluded from the study. 
Oral and topical antihistaminic and antireactive drugs 
(such as nasal corticosteroids or chromon) were withdrawn, 
respectively, 7 and 4 days before starting the study; subjects 
had to be free from upper airways infections (i.e. common 
cold) for at least the previous 6 weeks. 
Following the inclusion criteria, 12 subjects were selected 
and submitted to the experimental procedure. 
Twelve subjects well matched for age and sex [four males, 
eight females, mean age 23.8 ( & 6.5) years] with no history 
of atopy, rhinitis, asthma or chronic cough formed the 
control group. 
The study was approved by the local ethical committee. 
All subjects gave their informed consent to participate in 
the study. 
EXPERIMENTAL PROCEDURES 
Subjects were studied over three consecutive days. 
Day 1 
Airway response was assessed using a standardized metha- 
choline challenge test. Using a facial mask, subjects inhaled 
progressively doubling methacholine concentrations rang- 
ing from 0.125 to 16 mgmll’ through a disposable 
nebulizer driven by a constant air flow; methacholine 
challenge was preceded by inhalation of saline aerosol 
(0.9%) as control solution. Each inhalation lasted 2 min, 
and was followed by measurement of FEV,. 
Day 2 
Assessment of bronchial responsiveness to hypo-osmolar 
challenge by spirometric evaluation was performed before, 
and 2 and 4 min after a 5-min inhalation of ultrasonically 
nebulized distilled water through a mouthpiece with a nose 
clamp (13,14). Bronchial challenge was performed by 
means of an ultrasonic nebulizer (Syrius HAYER) with an 
output of 2 mllmin - i; flow-volume curves were obtained 
by an automated spirometer (Printer Spirometer Micro- 
Medical Ltd, Rochester, U.K.). FEV, decrease was used as 
an index of bronchial response. 
Day 3 
Assessment of bronchial responsiveness to hypo-osmolar 
challenge by monitoring transcutaneous 0, and CO, pres- 
sure (PtcO, and PtcCO,) was performed. Subjects were 
submitted to a 5-min inhalation of ultrasonically nebulized 
distilled water, through a mouthpiece with a nose clamp, 
while monitoring PtcCO, and PtcO,. Subjects were con- 
nected to a mono-electrode which was placed on the 
anterior side of the chest, heated to 45” and connected to a 
computer; PtcO, and PtcCO, values were recorded every 
10 s, and the difference from baseline was calculated by 
software (monitoring and recording system: Gasthmatic, 
Burke & Burke SpA, Milan, Italy) (8). The monitoring 
period lasted a total of 22 min: 3 min to record a steady 
baseline, 5 min to perform the challenge, and 14 min to 
monitor PtcO, and PtcCO, patterns at the end of the test. 
STATISTICAL ANALYSIS 
The paired t-test was used to compare basal PtcO,, PtcCO, 
and pre-challenge respiratory function in rhinitic vs normal 
subjects; the polynomial PtcO, and PtcCO, trends during 
and following hypo-osmolar solution in rhinitic vs healthy 
subjects were compared by analysis of variance for trends; 
PcO.05 was taken as the statistically significant level. 
Results 
BASELINE VALUES 
Mean basal PtcO,, PtcCO, and mean FEV, did not differ 
between the two groups, and were within the normal range. 
Values are reported in Table 1. 
METHACHOLINE INHALATION CHALLENGE 
Both normal and rhinitic subjects had PC,, 16 mg ml - ’ 
SPIROMETRIC RESPONSE TO UNDW 
CHALLENGE (TABLE I) 
No decrease in respiratory function, significant ,for bron- 
chial hyper-responsiveness, was found in either normal or 
rhinitic subjects after inhalation of ultrasonically nebulized 
distilled water. 
&co, AND Ptco, DURING AND 
FOLLOWING INHALATION OF UNDW (FIGS 
I AND 2) 
Rhinitics 
PtcCO, showed a sudden decrease immediately after the 
start of the challenge with the maximal value at the fourth 
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TABLE 1. Demographic and spirometric characteristics of the subjects; individual post-challenge 
levels of FEV,, and individual baseline values of transcutaneous PO, and PCO, (PtcO, and 
PtcCO,), expressed in mmHg (=kPa x 7.5) 
Sex Age Height 
FEV, FEV, 
pre post 
(1) % (1) % 
ptco, ptcco, 
(mmHg) (mmHg) 
Rhinitis subjects 
M 19 
F 22 
M 27 
F 27 
F 20 
M 32 
F 25 
M 38 
M 37 
F 30 
F 18 
M 21 
Mean 26.3 
(SD) (63) 
Normal subjects 
M 25 
F 27 
M 30 
F 35 
F 19 
M 24 
F 32 
F 18 
F 25 
M 32 
F 21 
M 20 
Mean 25.6 
(SD) (5.6) 
172 
165 
186 
167 
172 
172 
164 
166 
184 
166 
162 
167 
167 
165 
170 
160 
161 
170 
15x 
165 
161 
168 
162 
174 
4.00 95 3.85 -4 
3.25 96 3.23 = 
5.20 97 5.00 -4 
3.50 102 3.55 +1 
3.65 98 3.53 -4 
4.04 100 3.92 -3 
2.76 85 2.68 -3 
3.55 100 3.42 -4 
5.00 108 4.83 -4 
3.22 93 3.00 -7 
2.96 95 2.90 = 
3.77 98 3.85 +2 
3.74 97 3.64 - 2.5 
(0.74) (5) (0.71) (2.6) 
3.90 102 3.95 
3.20 90 3.10 
3.70 95 3.60 
2.75 91 2.70 
3.07 100 3.10 
4.00 100 4.02 
2.85 102 2.78 
3.28 100 3.30 
3.08 102 3.02 
3.88 109 3.78 
3.12 100 3.11 
4.44 112 4.22 
3.43 100 3.39 
(0.52) (6.3) (0.5) 
1 
-3 
-3 
-2 
= 
12 
= 
-2 
-3 
f5 
82 
86 
85 
89 
90 
91 
78 
78 
83 
70 
80 
84 
72 45 
88 41 
92 35 
86 45 
87 48 
86 37 
83 44 
76 42 
78 40 
80 36 
81 42 
80 40 
82.4 41.2 
(5.6) (3.9) 
43 
44 
38 
39 
42 
40 
42 
41 
39 
39 
44 
41 
;It 
minute and complete recovery at the eighth minute after the 
challenge; mean maximal fall was - 22% ( f 6.9) from 
baseline, range - lo-33%. 
PtcO, showed an increase during the challenge corre- 
sponding to 11.8% ( * 6.4) from baseline, range O-20%, and 
a subsequent decrease starting from the second minute 
after the test with maximal value corresponding to 
- 5.3% ( & 3.1) from baseline, range - l-12%, at the third 
minute. 
contvo1 group 
During inhalation, a slight decrease in PtcO,= - 4.1% 
( Z!Z 2) range - l-7%, was found; PtcO, increased slightly 
during the challenge, +2% from baseline, range O-5%, 
and decreased after the test with a mean maximal fall 
corresponding to - 3.3% (& 1.4) range - l-5%. 
STATISTICAL ANALYSIS 
The statistical comparison between blood gas changes 
induced by ultrasonically nebulized distilled water in 
rhinitic vs normal subjects was highly significant for 
maximal PtcCO, decrease (P=O.OOOl) and PtcO, increase 
(P=O,OOOl), but not for PtcO, decrease after the challenge 
(P=o~os). 
Discussion 
Airway response to a challenge is usually measured by the 
decrease in expiratory flows. Through continuous non- 
invasive monitoring of blood gas, significant changes in 
transcutaneous 0, and CO, were found in both asthmatics 
and atopic rhinitics, even at levelsof stimulus that do not 
cause any significant change in respiratory function (9). 
12 A. L. COG0 ET AL. 
. . 
,:’ ,.1 ,:’ 
------I 
,:’ ,‘.’ ,:’ .,I’ ,:’ ,;’ 
-351 I I I I I I I I I I 
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
Time (min) 
FIG. 1. Transcutaneous mean PCO, (PtcCO,) time course 
in normal (---) and rhinitic (. .) subjects during and 
after the challenge with ultrasonically nebulized distilled 
water (from 0 to 5 min). Values are expressed as percent- 
age difference from baseline. The maximal PtcCO, 
decrease was significantly higher in rhinitic compared to 
normal subjects. 
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FIG. 2. Transcutaneous mean PO, (PtcO,) time course in 
normal (---) and rhinitic (. .) subjects during and after 
the challenge with ultrasonically nebulized distilled water 
(from 0 to 5 min). Values are expressed as percentage 
difference from baseline. The maximal PtcO, increase 
was significantly higher in rhinitic compared to normal 
subjects. 
A group of subjects affected by chronic idiopathic rhinitis 
were studied, all of whom were spirometric non-responders 
to either methacholine or hypo-osmolar aerosol. The 
subjects were compared to a group of subjects without 
symptoms, either nasal or respiratory. 
The PtcCO, time course during hypo-osmolar aerosol 
administration differed greatly between rhinitics and nor- 
mal subjects; whilst PtcO, showed high variability among 
the rhinitic subjects, PtcCO, always decreased significantly 
during the challenge. 
These results therefore show that in a group of subjects 
with chronic idiopathic rhinitis with no evidence of airway 
responsiveness, hypo-osmolar aerosol induces significant 
hypocapnia (with concomitant hyperoxia), which seems to 
be the hallmark of blood gas changes induced in these 
subjects by inhalation of ultrasonically nebulized distilled 
water. 
A reduction in carbon dioxide is a consequence of higher 
than usual ventilation; pathological conditions able to 
induce this situation - such as drug poisoning, hypoxaemia, 
pulmonary vascular disease, brain disorders, hormonal 
imbalance (15) - can be excluded in these subjects. One can, 
therefore, reasonably assume that hypo-osmolar challenge 
per se is able to induce marked hyperventilation in chronic 
non-atopic rhinitic subjects. 
Distilled water acts as an irritant, stimulating sensitive 
nerve endings of the upper respiratory tract (pharynx and 
larynx) which in turn trigger several protective responses 
regulating both breathing pattern and airway size (16,17). 
For example, exposure to ozone causes rapid, shallow 
breathing during exercise in otherwise healthy subjects; 
this effect is due to the stimulation of irritant receptors 
(18) while inhalation of bronchoconstrictors such as 
methacholine and histamine induces respiratory responses 
characterized by an increase in minute ventilation (19). 
In airway inflammation, enhanced exposure of airway 
irritant receptors can be found. Empey (3) suggested 
that epithelial shedding associated with viral upper respir- 
atory tract infections could sensitize irritant receptors 
present in the trachea, inducing an altered sensitivity to 
broncho-active aerosols. 
Chronic rhinitis is associated with epithelial damage and 
inflammation of the airway mucosa, which might induce 
abnormal sensitivity of upper respiratory tract receptors 
located in pharynx and/or larynx. 
The authors speculate that the hyperventilatory response 
induced by inhalation of hypo-osmolar solution in patients 
affected by idiopathic chronic rhinitis with no spirometric 
response to bronchial challenge might be due to the effect 
of aerosols on sensitized upper respiratory tract irritant 
receptors, and that this response could be a marker of 
airway inflammation. 
The pathophysiology of chronic non-atopic rhinitis and 
the association between this nasal disorder and airway 
responsiveness are, however, still unclear. The percentage 
of chronic rhinitic subjects not responsive to bronchial 
challenge, is variable according to different surveys, but an 
interplay between upper non-allergic airway disorders and 
other respiratory tract disorders is suggested by many 
authors (S-7,10). 
Further investigations and a longitudinal study of these 
patients are needed to better understand the relationships 
between chronic rhinitis and hyperventilatory response to 
hypotonic aerosol and the underlying mechanisms. The 
presence of significant hypocapnia induced in this group of 
subjects by ultrasonically nebulized distilled water, in the 
absence of significant hypoxia, furthermore suggests that 
these two phenomena are not strictly related, and are 
instead probably due to different mechanisms (20). 
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